The Scientist

» drug development and culture

Most Recent

image: Warming Up to Brown Fat

Warming Up to Brown Fat

By | October 8, 2015

Scientists know how to turn on these fat-combusting cells. Can these energy burners be used to combat obesity?

6 Comments

image: Phase 3 Win for Gene Therapy

Phase 3 Win for Gene Therapy

By | October 6, 2015

The treatment restored sight among people with an inherited visual impairment.

0 Comments

image: Debating the Value of Anonymity

Debating the Value of Anonymity

By | October 5, 2015

PubPeer responds to criticism that anonymous post-publication peer review threatens the scientific process.

1 Comment

image: Ready, Willing, and Able

Ready, Willing, and Able

By | October 1, 2015

Researchers with disabilities are making their fields more accessible.

0 Comments

image: Biotech Stocks Take a Hit

Biotech Stocks Take a Hit

By | September 30, 2015

Some say the biotech bubble has burst over concerns that drug prices are too high—and may soon be regulated.

1 Comment

image: Riboswitch Flip Kills Bacteria

Riboswitch Flip Kills Bacteria

By | September 30, 2015

Scientists discover a novel antibacterial molecule that targets a vital RNA regulatory element.

4 Comments

image: Treating Toxoplasmosis

Treating Toxoplasmosis

By | September 25, 2015

While one company hikes the price of an old drug to treat the parasitic infection, academic researchers report that an approved blood pressure medication could be just what the doctor ordered.

4 Comments

image: Drug Pricing Incites Outrage

Drug Pricing Incites Outrage

By | September 22, 2015

Will public disgust over dramatic hikes in the cost of medications change industry practices?

0 Comments

image: Study: Men Get Bigger Start-Up Packages

Study: Men Get Bigger Start-Up Packages

By | September 17, 2015

A new analysis reveals yet another gender gap in science.

0 Comments

image: TS Picks: September 8, 2015

TS Picks: September 8, 2015

By | September 8, 2015

Pharma edition

0 Comments

Popular Now

  1. Monsanto Buys Rights to CRISPR
    The Nutshell Monsanto Buys Rights to CRISPR

    The US agribusiness secures a global, nonexclusive licensing agreement from the Broad Institute to use the gene-editing technology for agricultural applications.

  2. How Plants Evolved Different Ways to Make Caffeine
  3. Thomson Reuters Predicts Nobelists
    The Nutshell Thomson Reuters Predicts Nobelists

    According to citation statistics, researchers behind programmed cell death pathways and CRISPR/Cas9 are among those in line for Nobel Prizes this year.

  4. ESP on Trial
    Foundations ESP on Trial

    In the 1930s, parapsychologist Joseph Banks Rhine aimed to use scientific methods to confirm the existence of extrasensory perception, but faced criticisms of dubious analyses and irreproducible results.

RayBiotech